Patricia Williams
Nurse Practitioner · Elizabethtown, KYNPI 1285672451
Payments from drug & device makers
Across 167 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$467
- GSK$384
- AstraZeneca$241
- Amgen$216
- Bayer$136
- Pfizer$132
- plus $860 from 16 others
What the payments were for
- Food & beverage$2,435100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $467 |
| GSK | 30 | $384 |
| AstraZeneca(2 entities) | 14 | $241 |
| Amgen | 18 | $216 |
| Bayer | 9 | $136 |
| Pfizer | 8 | $132 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $122 |
| Phathom Pharmaceuticals, Inc. | 3 | $118 |
| Radius Health, Inc. | 8 | $113 |
| Novo Nordisk | 5 | $97 |
| Lilly USA, LLC | 5 | $88 |
| Johnson & Johnson | 5 | $87 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Upsher-smith Laboratories LLC | 2 | $40 |
| Merck | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Abbott | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Medtronic | 1 | $13 |
| Exact Sciences | 1 | $13 |
How this compares
$2,435 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $81,877 |
| FarxigaDapagliflozin Propanediol | 66 | $62,885 |
| OzempicSemaglutide | 36 | $59,862 |
| TrulicityDulaglutide | 34 | $59,749 |
| EliquisApixaban | 34 | $44,103 |
| ProliaDenosumab | 17 | $29,348 |
| JardianceEmpagliflozin | 17 | $27,881 |
| XareltoRivaroxaban | 30 | $27,272 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $19,736 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 22 | $19,576 |
| MounjaroTirzepatide | 13 | $18,223 |
| JanuviaSitagliptin Phosphate | 13 | $16,973 |
| KerendiaFinerenone | 20 | $16,348 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 55 | $16,261 |
| MyrbetriqMirabegron | 22 | $15,093 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Arexvy, Shingrix | $384 | $103,488164 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $88 | $77,97247 claims |
| AstraZenecaFarxiga | $241 | $62,88566 claims |
| Novo NordiskOzempic | $97 | $59,86236 claims |
| PfizerEliquis | $132 | $44,10334 claims |
| AmgenProlia | $216 | $29,34817 claims |
| Johnson & JohnsonXarelto | $87 | $27,27230 claims |
| MerckJanuvia | $35 | $16,97313 claims |
| BayerKerendia | $136 | $16,34820 claims |
| AbbVieSynthroid | $467 | $2,43971 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Elizabethtown
- Jennifer WhitsellElizabethtown$13K
- Tiffany RichardsonElizabethtown$10K
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.